Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effect of berberine on glucolipid metabolism, carotid thickness, vascular endothelial function, oxidative stress and intestinal flora in patients with coronary heart disease

Fengming Yang , Chuiyi Zeng, Zhenyi Chen

Department of Cardiology, Henan Provincial Hospital of Traditional Chinese Medicine, The Second Hospital Affiliated to Henan University of Chinese Medicine, Zhengzhou City, Henan Province 450002, China;

For correspondence:- Fengming Yang Email: yfming1220@outlook.com

Accepted: 3 January 2024 Published: 30 January 2024

Citation: Yang F, Zeng C, Chen Z. Effect of berberine on glucolipid metabolism, carotid thickness, vascular endothelial function, oxidative stress and intestinal flora in patients with coronary heart disease. Trop J Pharm Res 2024; 23(1):141-146 doi: 10.4314/tjpr.v23i1.18

© 2024 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of berberine on glucolipid metabolism, carotid thickness, vascular endothelial function, oxidative stress and intestinal flora in coronary heart disease (CHD) patients.

Methods: 68 patients with CHD admitted to the Department of Cardiology, Henan Provincial Hospital of Traditional Chinese Medicine, China were assigned to two groups of 34 patients each. Control group received anti-CHD treatment while study group was given 0.3 g of berberine three times daily for 4 weeks. Changes in glucolipid metabolism, carotid thickness, vascular endothelial function, oxidative stress and intestinal flora were assessed.

Results: Total cholesterol, triglyceride, tumor necrosis factor-α, interleukin (IL)-2 and IL-1β of CHD patients from study group were significantly decreased compared to control group (p < 0.05) while superoxide dismutase (p = 0.019) and total antioxidant capacity (p = 0.009) of CHD patients in study group were significantly increased. In addition, reduced endothelin-1 and elevated Nitric Oxide levels were shown in CHD patients in study group (p < 0.001). Furthermore, the carotid intima-media thickness decreased in study group, while Aquificae, Paraprevotella, Abiotrophia, Rubrobacterales, Bacteroidales and other microbes were abundant in the intestinal tract of study group patients.

Conclusion: Berberine improves glucolipid metabolism, carotid thickness, vascular endothelial function, oxidative stress and intestinal flora in CHD patients. Berberine may therefore be effective in the treatment of CHD. Further studies are, however, required to establish these claims.

Keywords: Berberine, Coronary heart disease, Glucolipid metabolism, Carotid thickness, Vascular endothelial function, Intestinal flora